AstraZeneca Buys Fusion Pharmaceuticals for US$2 B
By Lucy Haggerty
Pharma Deals Review: Vol 2024 Issue 3 (Table of Contents)
Published: 22 Mar-2024
DOI: 10.3833/pdr.v2024.i3.2862 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Reinforcing its commitment to transforming cancer treatments, AstraZeneca has agreed to acquire Fusion Pharmaceuticals for an initial value of US$2 B...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS